First name
E.
Last name
Gazit
Milardi, D., Gazit, E., Radford, S. E., Xu, Y., Gallardo, R. U., Caflisch, A., … Ramamoorthy, A. (2021). Proteostasis of islet amyloid polypeptide: a molecular perspective of risk factors and protective strategies for type II diabetes. Chemical Reviews, 121(3), 1845-1893. https://doi.org/10.1021/acs.chemrev.0c00981 (Original work published)
Arnon, Z. A., Vitalis, A., Levin, A., Michaels, T. C. T., Caflisch, A., Knowles, T. P. J., … Gazit, E. (2016). Dynamic Microfluidic Control of Supramolecular Peptide Self-Assembly. Nature Communications, 7, 13190. https://doi.org/10.1038/ncomms13190 (Original work published)
Scherzer-Attali, R., Convertino, M., Pellarin, R., Gazit, E., Segal, D., & Caflisch, A. (2013). Methylations of tryptophan-modified naphthoquinone affect its inhibitory potential toward Aβ aggregation. The Journal of Physical Chemistry B, 117(6), 1780-1789. https://doi.org/10.1021/jp309066p (Original work published)
Adler-Abramovich, L., Vaks, L., Carny, O., Trudler, D., Magno, A., Caflisch, A., … Gazit, E. (2012). Phenylalanine assembly into toxic fibrils suggests amyloid etiology in phenylketonuria. Nature Chemical Biology, 8(8), 701-706. https://doi.org/10.1038/nchembio.1002 (Original work published 2012)
Frydman-Marom, A., Convertino, M., Pellarin, R., Lampel, A., Shaltiel-Karyo, R., Segal, D., … Gazit, E. (2011). Structural basis for inhibiting β-amyloid oligomerization by a non-coded β-breaker-substituted endomorphin analogue. ACS Chemical Biology, 6(11), 1265-1276. https://doi.org/10.1021/cb200103h (Original work published)
Scherzer-Attali, R., Pellarin, R., Convertino, M., Frydman-Marom, A., Egoz-Matia, N., Peled, S., … Segal, D. (2010). Complete phenotypic recovery of an Alzheimer’s disease model by a quinone-tryptophan hybrid aggregation inhibitor. PLoS One, 5(6), e11101. https://doi.org/10.1371/journal.pone.0011101 (Original work published 2010)